Slideshow

August 29, 2017

6 Signs Your Patient Is at Risk for Treatment-Resistant Depression

Author(s):

Alessandro Serretti, MD, PhD,Chiara Fabbri, MD

What factors predispose patients to TRD and what treatment strategies achieve response? Find out here, with a bonus case vignette.

Related Content

December 19th 2024

What You Need to Know About NeuroStar Advanced TMS Therapy for Adolescents With Major Depressive Disorder

Melissa Fickey, MD

October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP

December 10th 2024

Psychopharmacology Innovations

John J. Miller, MD

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

December 4th 2024

Which Patients Respond to Ketamine vs ECT for Treatment-Resistant Depression?

Kenneth J. Bender, PharmD, MA

December 3rd 2024

sNDA Submitted: Lumateperone as Adjunctive Therapy for Major Depressive Disorder

Leah Kuntz